Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07852442) titled 'Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS or SC Genotype (DrepAgreg)' on Sept. 25.
Study Type: Observational
Primary Sponsor: Centre Hospitalier Universitaire de la Guadeloupe
Condition:
Sickle Cell Disease
Venous Thromboembolism
Recruitment Status: Not recruiting
Date of First Enrollment: October 15, 2026
Target Sample Size: 60
Countries of Recruitment:
France
Guadeloupe
France
Guadeloupe
To know more, visit https://clinicaltrials.gov/study/NCT07852442
Disclaimer: Curated by HT Syndication....